188 related articles for article (PubMed ID: 33453248)
1. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
[TBL] [Abstract][Full Text] [Related]
2. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin.
Shen Q; Yao Q; Sun J; Feng L; Lu H; Ma Y; Liu L; Wang F; Li J; Yue Y; Jin H; Wang X
FEBS Lett; 2014 Jan; 588(1):184-91. PubMed ID: 24316511
[TBL] [Abstract][Full Text] [Related]
4. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
[TBL] [Abstract][Full Text] [Related]
5. MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer.
Wu MY; Fu J; Xiao X; Wu J; Wu RC
Cancer Lett; 2014 Nov; 354(2):311-9. PubMed ID: 25173798
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer.
Sun J; Piao J; Li N; Yang Y; Kim KY; Lin Z
FEBS J; 2020 May; 287(10):2118-2133. PubMed ID: 31692265
[TBL] [Abstract][Full Text] [Related]
7. [Efflect of miR-34a-Tangeted Regulation of HDACI on Apoptosis of AML Cells].
Wen C; Xie YK; Chen YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):790-795. PubMed ID: 31204933
[TBL] [Abstract][Full Text] [Related]
8. Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.
Lin L; Jiang H; Huang M; Hou X; Sun X; Jiang X; Dong X; Sun X; Zhou B; Qiao H
Oncol Rep; 2015 Aug; 34(2):663-72. PubMed ID: 26035691
[TBL] [Abstract][Full Text] [Related]
9. miR-520h is crucial for DAPK2 regulation and breast cancer progression.
Su CM; Wang MY; Hong CC; Chen HA; Su YH; Wu CH; Huang MT; Chang YW; Jiang SS; Sung SY; Chang JY; Chen LT; Chen PS; Su JL
Oncogene; 2016 Mar; 35(9):1134-42. PubMed ID: 25982274
[TBL] [Abstract][Full Text] [Related]
10. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.
Mohammady M; Ghetmiri SI; Baharizade M; Morowvat MH; Torabi S
Curr Pharm Biotechnol; 2019; 20(8):665-673. PubMed ID: 31244419
[TBL] [Abstract][Full Text] [Related]
12. miR-34a Targets HDAC1-Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells.
Zhao Q; Li S; Li N; Yang X; Ma S; Yang A; Zhang H; Yang S; Mao C; Xu L; Gao T; Yang X; Zhang H; Jiang Y
J Cell Biochem; 2017 Dec; 118(12):4617-4627. PubMed ID: 28485501
[TBL] [Abstract][Full Text] [Related]
13. miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer.
Geng W; Song H; Zhao Q; Dong K; Pu Q; Gao H; Lv Y
Biomed Res Int; 2020; 2020():9512793. PubMed ID: 32775453
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
Irani S; Paknejad M; Soleimani M; Azam S
Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
16. Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line.
Yagi Y; Fushida S; Harada S; Kinoshita J; Makino I; Oyama K; Tajima H; Fujita H; Takamura H; Ninomiya I; Fujimura T; Ohta T; Yashiro M; Hirakawa K
J Exp Clin Cancer Res; 2010 Nov; 29(1):149. PubMed ID: 21080974
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
18. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
Sharma P; Kumar S
Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
[TBL] [Abstract][Full Text] [Related]
20. Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?
Yahya SMM; Abd-Elhalim MM; Abdelhamid AO; Eskander EF; Elsayed GH
Asian Pac J Cancer Prev; 2021 Mar; 22(3):819-826. PubMed ID: 33773546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]